Thank you, Madam Chair.
I would like to thank all of you for inviting me and my colleague, Dr. Brian Lichty, to appear today to discuss domestic manufacturing capacity for a COVID-19 vaccine.
My name is Dr. Karen Mossman, and I am the vice-president for research at McMaster University. I'm also a professor in medicine and a virologist by training.
Very early on, my team was involved in isolating SARS-CoV-2, the agent responsible for the outbreak of COVID-19. Isolating and propagating the virus has enabled researchers across Canada and the world to better understand the virus and work on potential solutions.